基于CT的影像组学列线图用于结直肠癌术前预测微卫星不稳定状态及临床结局:一项多中心研究
该回顾性多中心研究纳入三中心497例结直肠癌患者,构建整合影像组学特征与年龄、部位、厚度的列线图,术前预测微卫星不稳定状态,训练组及验证组AUC为0.89、0.87、0.88、0.86,并成功对II期患者进行预后分层(HR=0.357,p=0.022)。
要点
- 列线图预测MSI的AUC在训练组0.89、内部验证组0.87、两个外部验证组0.88和0.86。
- 列线图性能优于临床模型(p<0.05),可辅助术前无创评估MSI状态。
- 列线图可对II期结直肠癌患者进行预后分层(HR=0.357,p=0.022)。
核心结论
- 基于CT的影像组学列线图在预测结直肠癌MSI状态和预后分层方面表现出良好性能。
研究设计与样本
- 回顾性多中心研究,纳入三个中心的497例结直肠癌患者,采用LASSO回归筛选特征并构建影像组学标签,结合单因素和多因素逻辑回归识别的临床变量构建列线图。
诊断标准与关键数值
- 影像组学标签由10个与MSI状态相关的影像组学特征组成。
- 列线图整合影像组学标签与独立预测因子(年龄、部位、厚度)。
- 列线图预测MSI的AUC:训练组0.89(95%CI 0.83-0.95),内部验证组0.87(95%CI 0.79-0.95),外部验证组1为0.88(95%CI 0.81-0.96),外部验证组2为0.86(95%CI 0.78-0.93)。
- 列线图性能优于临床模型(p<0.05)。
- 生存分析显示列线图可对II期结直肠癌患者进行预后分层(HR=0.357,p=0.022)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To develop and validate a computed tomography (CT)-based radiomics nomogram for preoperative prediction of microsatellite instability (MSI) status and clinical outcomes in colorectal cancer (CRC) patients.
MATERIALS AND METHODS: This retrospective study enrolled 497 CRC patients from three centres. Least absolute shrinkage and selection operator regression was utilised for feature selection and constructing the radiomics signature. Univariate and multivariate logistic regression analyses were employed to identify significant clinical variables. The radiomics nomogram was constructed by integrating the radiomics signature and the identified clinical variables. The performance of the nomogram was evaluated through receiver operating characteristic curves, calibration curves, and decision curve analysis. Kaplan-Meier analysis was performed to investigate the prognostic value of the nomogram.
RESULTS: The radiomics signature comprised 10 radiomics features associated with MSI status. The nomogram, integrating the radiomics signature and independent predictors (age, location, and thickness), demonstrated favourable calibration and discrimination, achieving areas under the receiver operating characteristic (ROC) curves (AUCs) of 0.89 (95% confidence interval [CI]: 0.83-0.95), 0.87 (95% CI: 0.79-0.95), 0.88 (95% CI: 0.81-0.96), and 0.86 (95% CI: 0.78-0.93) in the training cohort, internal validation cohort, and two external validation cohorts, respectively. The nomogram exhibited superior performance compared to the clinical model (p<0.05). Additionally, survival analysis demonstrated that the nomogram successfully stratified stage II CRC patients based on prognosis (hazard ratio [HR]: 0.357, p=0.022).
CONCLUSION: The radiomics nomogram demonstrated promising performance in predicting MSI status and stratifying the prognosis of patients with CRC.
引用
- Li M, Xu G, Cui Y, et al. CT-based radiomics nomogram for the preoperative prediction of microsatellite instability and clinical outcomes in colorectal cancer: a multicentre study. Clin Radiol. 2023. PMID: 37487841. doi:10.1016/j.crad.2023.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。